Hannah B Hanley
Overview
Explore the profile of Hannah B Hanley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carlock M, Allen J, Hanley H, Ross T
PLoS One
. 2024 Jun;
19(6):e0301157.
PMID: 38917104
Participants between the ages of 10-86 years old were vaccinated with split-inactivated influenza vaccine (Fluzone®) in six consecutive influenza seasons from 2016-2017 to 2021-2022. Vaccine effectiveness varies from season to...
2.
Tong X, Deng Y, Cizmeci D, Fontana L, Carlock M, Hanley H, et al.
J Immunol
. 2023 Nov;
212(1):24-34.
PMID: 37975667
Influenza viruses infect 5-30% of the world's population annually, resulting in millions of incidents of hospitalization and thousands of mortalities worldwide every year. Although annual vaccination has significantly reduced hospitalization...
3.
Sung M, Billings W, Carlock M, Hanley H, Bahl J, Handel A, et al.
J Infect Dis
. 2023 Aug;
229(2):322-326.
PMID: 37624957
The long-term effects of host factors on vaccine-elicited immune responses have not been well studied, and the interactions of host factors with annual influenza vaccinations are yet to be explored....
4.
Ebell M, Forgacs D, Shen Y, Ross T, Hulme C, Bentivegna M, et al.
J Am Board Fam Med
. 2022 May;
35(3):570-578.
PMID: 35641057
Introduction: Universities are unique settings with large populations, congregate housing, and frequent attendance of events in large groups. However, the current prevalence of previous COVID-19 infection in university students, including...
5.
Forgacs D, Silva-Moraes V, Sautto G, Hanley H, Gattiker J, Jefferson A, et al.
Vaccines (Basel)
. 2022 May;
10(5).
PMID: 35632452
In order to longitudinally track SARS-CoV-2 antibody levels after vaccination or infection, we assessed anti-RBD antibody levels in over 1000 people and found no significant decrease in antibody levels during...
6.
Simon V, Kota V, Bloomquist R, Hanley H, Forgacs D, Pahwa S, et al.
mSphere
. 2022 May;
7(3):e0017922.
PMID: 35586986
To understand reinfection rates and correlates of protection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we established eight different longitudinal cohorts in 2020 under the umbrella of the PARIS...
7.
Forgacs D, Moraes V, Hanley H, Gattiker J, Jefferson A, Ross T
bioRxiv
. 2022 Mar;
PMID: 35313572
As of March 2022, there have been over 450 million reported SARS-CoV-2 cases worldwide, and more than 4 billion people have received their primary series of a COVID-19 vaccine. In...
8.
Forgacs D, Jang H, Abreu R, Hanley H, Gattiker J, Jefferson A, et al.
Front Immunol
. 2021 Oct;
12:728021.
PMID: 34646267
As the COVID-19 pandemic continues, the authorization of vaccines for emergency use has been crucial in slowing down the rate of infection and transmission of the SARS-CoV-2 virus that causes...
9.
Forgacs D, Jang H, Abreu R, Hanley H, Gattiker J, Jefferson A, et al.
bioRxiv
. 2021 Jun;
PMID: 34100015
As the COVID-19 pandemic continues, the authorization of vaccines for emergency use has been crucial in slowing down the rate of infection and transmission of the SARS-CoV-2 virus that causes...